NASDAQ · Financial Statements
Arena Pharmaceuticals, Inc. (ARNA) Financial Statements
$99.99
NASDAQ: ARNA
Overview Financials Dividend Arena Pharmaceuticals, Inc. most recently reported annual revenue of $0, net profit of $-621.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2017 2018 2019 2020 2021 Revenue $21.0M $18.0M $806.0M $0 $0 Operating Profit $-92.0M $-145.0M $483.0M $-427.0M $-612.0M Net Profit $-91.0M $-29.0M $398.0M $-405.0M $-621.0M EPS $-2.77 $-0.62 $7.69 $-7.39 $-11.33 Op Margin -431.0% -805.7% 59.9% -133742.6% -1133840.7%
Balance Sheet (USD)
Metric 2017 2018 2019 2020 2021 Total Assets $339.0M $687.0M $1.2B $1.2B $785.0M Total Liabilities $132.0M $81.0M $103.0M $110.0M $111.0M Cash $159.0M $161.0M $243.0M $220.0M $225.0M Borrowings $62.0M $53.0M $49.0M $46.0M $41.0M
Cash Flow (USD)
Metric 2017 2018 2019 2020 2021 Operating Cash Flow $-67.0M $-132.0M $569.0M $-353.0M $-452.0M Investing Cash Flow $-112.0M $-255.0M $-503.0M $-22.0M $250.0M Financing Cash Flow $245.0M $385.0M $10.0M $351.0M $135.0M Net Cash Flow $68.0M $2.0M $82.0M $-24.0M $5.0M Free Cash Flow $-67.0M $-133.0M $564.0M $-354.0M $-523.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.29 EV / EBITDA 0.30 FCF Yield — Quick Ratio 8.59 Interest Coverage -147.22 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock